Back
CVE-2007-6763
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access…
High8.8EPSS 1.3%
- Published
- Updated
- Reserved
- Assigned by
- mitre
Description
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
Scores
| Scored by | CVSS | Score | Vector |
|---|---|---|---|
| NVDNVD · Modified | 3.0 | High8.8 | CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
- EPSS (exploitation in 30 days)
- 1.3% · top 29% of all CVEs (2 Nov 2026)
Loading the EPSS history…
The list uses the assigner's score when there is one, then CISA's, then NVD's: High 8.8.
Weakness
Affected products
n/a
- affected n/a
References (1)
- http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf (opens in a new tab)x_refsource_MISCx_transferred
Sources
The same CVE in the primary databases and aggregators, to check against.
- CVE.org record (opens in a new tab)
- CVE List JSON (GitHub) (opens in a new tab)
- NVD (opens in a new tab)
- FIRST EPSS (opens in a new tab)
- OSV.dev (opens in a new tab)
- GitHub Advisories (opens in a new tab)
- CIRCL Vulnerability-Lookup (opens in a new tab)
Record last updated .